The 2020 meeting will be held November 11–13, 2020 in a virtual format. More details to follow.
Invited speaker: Arthur Lander, University of California, Irvine
“Collective cell behaviors at the onset of cancer”
Invited speaker: Michael Murrell, Yale University
“Tissue Pressure drives traction-independent cellular flows”
Selected Abstract: Almudena Espin-Perez, Stanford University
“System level control of lineage plasticity in pancreas cancer”
Selected Abstract: Shubham Tripathi, Rice University
“A Mechanistic Modeling Framework Reveals the Key Principles Underlying Tumor Metabolism”
Invited speaker: James Heath, Institute of Systems Biology
“Single Cell transcriptomic, proteomic, and metabolomic methods for tumor tissue analysis”
Invited speaker: Christina Curtis, Stanford University
“Characterizing the eco-evolutionary dynamics of tumor progression and resistance”
Selected Abstract: Robert A Beckman, Georgetown University
“Extensive Subclonal Mutational Diversity in Human Colorectal Cancer and Its Significance”
Selected Abstract: Mark Smithson, University of Utah
“Inferring evolutionary history of metastases with class and novel population genetic analyses”
Invited speaker: Trachette Jackson, University of Michigan
“Mathematical model of Targeted Molecular Therapeutics”
Invited speaker: Kevin Janes, University of Virginia
“Systems-level identification of a single-cell bottleneck in premalignant glioma”
Selected Abstract: Hatice Osmanbeyoglu, University of Pittsburgh
“SPaRTAN, a computational framework for linking surface proteins to transcriptional regulators and single-cell genomic states”
Selected Abstract: Sabrina L. Spencer, University of Colorado-Boulder
“Melanoma subpopulations that rapidly escape MAPK pathway inhibition rely on stress signalling and incur DNA damage”
Invited speaker: Pamela Kreeger, University of Wisconsin-Madison
“Systems approaches to ovarian cancer metastasis”
Invited speaker: Melody Swartz, University of Chicago
“Systems approaches to modeling the tumor-lymph-immune interface”
Selected Abstract: Dimitrios Sidiropoulos, Johns Hopkins University
“Integrative characterization of the Her2+ Breast Tumor Microenvironment with Entinostat & Immune Checkpoint Blockade Combination Therapies”
Selected Abstract: Janani Baskaran, Tufts University
“Cell shape, and not 2D migration, predicts extracellular matrix-driven 3D cell invasion in breast cancer”
Invited speaker: Birgit Schoeberl, Novartis Institute for BioMedical Research
“Application of Systems Pharmacology in Drug Development”
Invited speaker: Sourav Bandyopadhyay, University of California, San Francisco
“An integrative approach to identify reproducible synthetic lethal interactions in cancer”
Selected Abstract: Andrew D Raddatz, Georgia Institute of Technology
“Kinetic Modeling of Nrf-2 Regulated Redox Metabolism Predicts Head and Neck Cancer Response to Reactive Oxygen Species Generating Chemotherapies”
Selected Abstract: Farnaz Mohammadi, University of California, Los Angeles
“Drug Treatment Induces Cell Cycle Pseudo-Synchronization Due to Phase Transit Times.”
Invited speaker: Thomas Yankeelov, University of Texas at Austin
“Towards personalized treatment regimens via quantitative imaging and mathematical modeling”
Invited speaker: Stacey Finley, University of Southern California
“Understanding and optimizing cell-based immunotherapies using systems biology models”
Selected Abstract: Emily Marcisak, Johns Hopkins University
“Matrix factorization of single-cell RNA-sequencing identifies novel immune cell states that project across species, cancer type, and infectious disease”
Selected Abstract: Zuzana Tatarova, Oregon Health Sciences University
“Personalized Combination Treatments and Early Anti-Tumor Immunity in Breast Cancer”
Note: Invited talks will be limited to 25 minutes. Selected talks will be limited to 15 minutes.